Other

AstraZeneca opens research center as UK builds science hub

Prince Charles praised Cambridge as a center of scientific collaboration Tuesday as the pharmaceutical company AstraZeneca opened a 1 billion-pound ($1.34 billion) research center, hoping to build on work in developing one ...

Genetics

Genome editing to treat human retinal degeneration

Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness. Technological advances in gene editing, continuing safety ...

Diseases, Conditions, Syndromes

Viral sequencing can reveal how SARS-CoV-2 spreads and evolves

The emergence of SARS-CoV-2 virus variants that are adding twists in the battle against COVID-19 highlight the need for better genomic monitoring of the virus, says Katia Koelle, associate professor of biology at Emory University.

Genetics

Gene therapy for inherited blindness

Retinitis pigmentosa is the most prevalent form of congenital blindness. Using a retinitis pigmentosa mouse model, LMU researchers have now shown that targeted activation of genes of similar function can compensate for the ...

page 36 from 40